| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |